Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124889433 | 12488943 | 3 | F | 20160812 | 20160622 | 20160819 | EXP | US-BIOGEN-2016BI00253282 | BIOGEN | 0.00 | F | Y | 89.00000 | KG | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124889433 | 12488943 | 1 | PS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 124889433 | 12488943 | 2 | SS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 124889433 | 12488943 | 3 | SS | TYSABRI | NATALIZUMAB | 1 | Unknown | 125104 | UNKNOWN | ||||||||||
| 124889433 | 12488943 | 4 | C | ANGELIQ | DROSPIRENONEESTRADIOL | 1 | Oral | 0 | TABLETS | QD | |||||||||
| 124889433 | 12488943 | 5 | C | AZOPT | BRINZOLAMIDE | 1 | Ophthalmic | O.U. (BOTH EYES) | 0 | 1 | PCT | SUSPENSION | TID | ||||||
| 124889433 | 12488943 | 6 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 1 TAB PO IN MORNING; 2 TAB PO AT NIGHT | 0 | 10 | MG | TABLETS | TID | ||||||
| 124889433 | 12488943 | 7 | C | BETIMOL | TIMOLOL | 1 | Ophthalmic | 0 | 1 | GTT | SOLUTION | BID | |||||||
| 124889433 | 12488943 | 8 | C | FLONASE | FLUTICASONE PROPIONATE | 1 | Nasal | 50 MCG/INH NASAL SPRAY, PRN (WHEN NEEDED) | 0 | NASAL SPRAY | QD | ||||||||
| 124889433 | 12488943 | 9 | C | LISINOPRIL. | LISINOPRIL | 1 | Oral | 0 | 20 | MG | PREPARATION FOR ORAL USE(NOS) | QD | |||||||
| 124889433 | 12488943 | 10 | C | MYRBETRIQ | MIRABEGRON | 1 | Oral | 0 | 50 | MG | TABLETS | QD | |||||||
| 124889433 | 12488943 | 11 | C | NEURONTIN | GABAPENTIN | 1 | Oral | 0 | 300 | MG | CAPSULES | BID | |||||||
| 124889433 | 12488943 | 12 | C | PROZAC | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 10 | MG | CAPSULE | QD | |||||||
| 124889433 | 12488943 | 13 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 40 MG, PO, QHS | 0 | 40 | MG | PREPARATION FOR ORAL USE(NOS) | |||||||
| 124889433 | 12488943 | 14 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | Oral | 1000 IU ORAL TABLETS; 2000 IU; 2 TAB DAILY | 0 | TABLETS | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124889433 | 12488943 | 1 | Multiple sclerosis |
| 124889433 | 12488943 | 4 | Product used for unknown indication |
| 124889433 | 12488943 | 5 | Product used for unknown indication |
| 124889433 | 12488943 | 6 | Product used for unknown indication |
| 124889433 | 12488943 | 7 | Product used for unknown indication |
| 124889433 | 12488943 | 8 | Product used for unknown indication |
| 124889433 | 12488943 | 9 | Product used for unknown indication |
| 124889433 | 12488943 | 10 | Product used for unknown indication |
| 124889433 | 12488943 | 11 | Product used for unknown indication |
| 124889433 | 12488943 | 12 | Product used for unknown indication |
| 124889433 | 12488943 | 13 | Product used for unknown indication |
| 124889433 | 12488943 | 14 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124889433 | 12488943 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124889433 | 12488943 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124889433 | 12488943 | 2 | 201506 | 0 | ||
| 124889433 | 12488943 | 3 | 201406 | 0 |